Your SlideShare is downloading. ×
0
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Dr. gert vilhelm balling
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Dr. gert vilhelm balling

57

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
57
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Academia and Industry: Finding the Balance; Danish TT and spin-outs based on public research results
  • 2. PRO landscape 17 PROs – 13 with IP activities: - 8 Universities – 7 with IP - 5 Regional Hospitals – 4 with IP - 4 Gvt. Research Inst. – 2 with IP
  • 3. Research commercialisation Key figures 2010 328 Invention disclosures 122 Patent applications 103 LOAs 11 spinouts
  • 4. Direct and Indirect measures fromcentral administration since 2000Direct: Indirect• IP Ownership regime • Increased investment in research base• Refund of universitypatenting costs • University management reform’• Development of Improved • Reform of institutionaltechnology transferstructures exploitation structure of university• Proof of Concept Funding IP • University performance contracts• Training of technologytransfer officers • Individual appraisal and reward systems• Guidelines and model IPR-contracts • Support for universty spin outs• Annual commercialisationsurvey • IP training for students
  • 5. Licensing and spinouts 2000-2010
  • 6. TTO staff educational profile 2006-2010 FT E s70,0 9,5 10,360,0 9,0 8,0 8,4 17,950,0 10,3 19,2 10,940,0 15,4 9,3 13,3 18,2 20,230,0 13,720,0 28,0 26,6 16,7 19,4 20,310,0 0,0 2006 2007 2008 2009 2010 Lawyer Business Science Other
  • 7. KTO Staff 2008. Other (Proton Europe) EU DK Italy Spain countries No. of % of No. of % of No. % of No. of % of No. of % of KTOs KTOs KTOs KTOs of KTOs KTOs KTOs KTOs KTOs KTOs0-1 9 6.5% 5 38.5% 3 6.4% 1 1.6% 0 0.%1-2 25 18.1% 1 7.7% 17 36.2% 5 7.9% 2 13.3%2-3 14 10.1% 1 7.7% 8 17.% 4 6.3% 1 6.7%3-4 16 11.6% 2 15.4% 10 21.3% 3 4.8% 1 6.7%4-5 12 8.7% 0 0.% 3 6.4% 6 9.5% 3 20.%5-6 4 2.9% 0 0.% 1 2.1% 3 4.8% 0 0.%6-8 14 10.1% 2 15.4% 2 4.3% 8 12.7% 2 13.3%8-10 9 6.5% 1 7.7% 2 4.3% 5 7.9% 1 6.7%10-15 14 10.1% 1 7.7% 1 2.1% 12 19.% 0 0.%15-20 7 5.1% 0 0.% 0 0.% 6 9.5% 1 6.7%20-30 6 4.3% 0 0.% 0 0.% 4 6.3% 2 13.3%> 30 8 5.8% 0 0.% 0 0.% 6 9.5% 2 13.3%Total number of KTOs 138 100.% 13 100.% 47 100.% 63 100.% 15 100.%Total FTEs 1,335.0 54.2 179.9 811.2 289.8Average FTEs per KTOs 9.7 4.2 3.8 12.9 19.3
  • 8. Goal & ressources of Copenhagen Spin-outs Overall goal: To increase the exploitation of research results and thereby increase the number of sustainable biotech companies through an intensified collaboration between key players Specific goal: To deliver 21 sustainable biotech spin-outs by end of 2014 (double up the national output) [month 10: 21 projects in development phase] Budget: 5,4 Mill EUR [EU Regional fund (2,7 Mill EUR), Growth Forum (1,1 Mill EUR), Partners (1,6 Mill EUR)]
  • 9. The partner group consists of all TT players, from initial idea to spin-out Research institutions: University of Research parks: Copenhagen Copenhagen Bio Science Capital Region’s Park (COBIS) hospitals Scion DTU Technical University of Symbion DenmarkBranch organisations: Seed Funds:Danish Biotech (Investor 2)The Danish Associationof the Pharmaceutical NOVO SEEDsIndustry (LIF) SEED Capital Innovation incubators (Investor 1): Mentors: CAT Innovation Volunteer mentors with DTU Symbion Innovation high spin-out competences from the Biotech industry
  • 10. Phase 2 Securement of IP rights Assembly of team Courses, ‘clinics’ (Accelerace) Establishment of local mini Proof of Concept program Preparation of Business PlanEvaluation phase Commercialisation phase 0-2 mdr 2-30 mdr Mentors from TTO Project Researchers Tech Scout Investors industry Pilot Research 10 Parks
  • 11. 5 Points in Academia-Industry collaboration adressed by CSO• Change of mindset among scientists – Introduce and support entrepreneurship culture• Secure resources at the TTO for spin-outs – Hire people enough with proper qualifications, long term basis.• Earlier involvement of industry via collaboration – Early involvement, but with a clear and transparent policy• Setting the team and picking the roles in the Spin-out – competences, driving factors, expectations• Keep the pace up and the bureaucracy down – Momentum is important as well as diminishing unnecessary administration
  • 12. Thank you for listening www.copenhagenspin-outs.dkProject managerGert Vilhelm Ballinggert.balling@adm.ku.dk

×